Aprepitant makes a difference for chemo-induced vomiting

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1550, 2006-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant

By Sankhala Kamalesh K   Pandya Devesh M   Sarantopoulos John   Soefje Scott A   Giles Francis J   Chawla Sant P  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. : 1607-1614

Informa Healthcare

Access to resources Recommend Favorite

Chemo-induced neutropenia: impact under-appreciated

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 581, 2009-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Safety evaluation of aprepitant for the prevention of chemotherapy-induced nausea and vomiting

By Ruhlmann Christina H   Herrstedt Jøørn  

Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. : 449-462

Informa Healthcare

Access to resources Recommend Favorite

Aprepitant: A Review of its Use in the Prevention of Chemotherapy-Induced Nausea and Vomiting

By Dando T.M.   Perry C.M.  

Drugs, Vol. 64, Iss. 7, 2004-01 ,pp. : 777-794

Adis International

Access to resources Recommend Favorite

Aprepitant plus standard therapy prevents acute and delayed chemotherapy-induced nausea and vomiting

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 12, 2004-12 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite